HAVN Life Sciences IncCanadian Securities Exchange:HAVNView on Over The Counter Market
- LAST PRICE0.0300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots0.0200/ 2
- Open / Previous Close--- / 0.0300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
HAVN Life Sciences Inc | 860.4K | 0.0x | --- |
Entheon Biomedical Corp | 1.2M | -3.0x | --- |
Waverley Pharma Inc | 810.0K | -0.2x | --- |
Optimind Pharma Corp | 549.6K | -0.5x | --- |
Lophos Holdings Inc | 859.6K | -0.7x | --- |
Chitogenx Inc | 832.3K | -0.2x | --- |
Company Information
HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. The Company has two business divisions: HAVN Labs and HAVN Retail. The HAVN Labs division is engaged in the development of research protocols to cover the production of Psilocybe spp. Through its research division, HAVN Labs, it has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research. The HAVN Retail division formulates and sells natural health products (NHPs) using compounds. It offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.
Contact Information
- Headquarters
- 605 - 130 Brew StreetPORT MOODY, BC, Canada V3H 0E3
- Phone
- 604-370-9520
- Fax
- ---
Executives
- Chairman of the Board
- Victor Neufeld
- Director and Chief Executive Officer
- Tim Moore
- Vice Chairman of the Board, Independent Director
- Ricky Brar
- Chief Financial Officer
- Gordon Clissold
- Chief Operating Officer
- Jenna Pozar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $860.4K |
|---|---|
Revenue (TTM) | $587.0K |
Shares Outstanding | 28.6M |
HAVN Life Sciences Inc does not pay a dividend. | |
Beta | --- |
EPS | $-3.06 |
Book Value | $0.62 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,619.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
